Laura Deming explains the new age of investing in longevity.
Laura Deming is the founder and full-time partner at The Longevity Fund, an early stage venture capital fund backing companies which target the ageing process to treat disease, with investments in gene editing, small molecule therapeutics, and novel methods to treat disease.
Version: 20241125
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.